OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Table. 2. Cytogenetic and molecular genetic characteristics of patients with non-cryptic NUP98 rearrangement
Case No. Dx Karyotype NUP98 FISH (%) Candidate partner gene Identified partner gene Breakpoint FLT3-ITD Targeted NGS
1 AML 46,XY,inv(11)(p15q22)[19]/46,XY[1] NA DDX10 DDX10 NUP98 exon 14::DDX10 exon 7 ND NA
2 AML 46,XY,inv(11)(p15q22)[12]/46,idem,del(5)(q22q33)[5]/46,XY[3] 1F1R1G (59.5%) DDX10 DDX10 NUP98 exon 14::DDX10 exon 7 ND KRAS c.35G>T, p.G12V (33.8%); WT1 c.1356_1358delinsTTC, p.Q452_C453delinsHS (30.0%)
3 MDS 46,XX,inv(11)(p15q22)[14]/46,XX[6] 1F1R1G (58.0%) DDX10 DDX10 NUP98 exon 14::DDX10 exon 7 NA NA
4 CMML-2; AML 46,XX,t(7;11)(p15;p15)[19]/46,XX[1] 1F1R1G (91.5%) HOXA9, HOXA11, HOXA13 HOXA9 NUP98 exon 12::HOXA9 exon 1 ND NA
5 AML 46,XX,t(7;11)(p15;p15)[20] 1F1R1G (92.5%) HOXA9, HOXA11, HOXA13 HOXA9 NUP98 exon 11::HOXA9 exon 1 ND ND
6 AML 49,XX,+4,t(7;11)(p15;p15),+8,+15[20] 1F1R1G (83.5%) HOXA9, HOXA11, HOXA13 NA* NA ND NA
7 MDS-EB2; AML 46,XX,t(9;11)(p22;p15)[20] 1F1R1G (78.5%) PSIP1 PSIP1 NUP98 exon 9::PSIP1 exon 7 NA NA
8 AML 46,XY,t(9;11)(p22;p15)[19]/46,XY[1] 1F1R1G (94.0%) PSIP1 PSIP1 NUP98 exon 9::PSIP1 exon 5 ND PHF6 c.902_903insGGGATAA, p.Y301* (90.0%)
9 AML 46,XX,t(1;11)(q24;p15)[19]/46,XX[1] 1F1R1G (82.0%) PRRX1 PRRX1 NUP98 exon 11::PRRX1 exon 2 ND NA
10 AML 46,XX,t(11;12)(p15;q13)[5]/46,XX[15] 1F1R1G (80.5%) HOXC13, HOXC11, RARG HOXC11 Inconclusive D NA
11 AML 47,XY,t(11;16)(p15;q23),+21[17]/46,XY[3] 1F1R1G (43.5%) Unknown NA NA ND ASXL1 c.1934dup, G646Wfs*12 (31.9%); DNMT3A c.917G>A, p.W306* (41.8%); DNMT3A c.2111T>G, p.V704G (39.6%); IDH2 c.419G>A, p.R140Q (38.4%); STAG2 c.1416+2T>C, p.? (81.2%)

*RT-PCR was not available because of the lack of a sample.

Multiple bands were observed on RT-PCR electrophoresis, and sequencing yielded inconclusive results.

Targeted RT-PCR could not be performed for candidate partner genes because the partner gene of the NUP98 rearrangement at the 16q23 locus was unknown.

Abbreviations: Dx, diagnosis; FLT3-ITD, FLT3-internal tandem duplication; NGS, next-generation sequencing; MDS, myeloid dysplastic neoplasm; CMML, chronic myelomonocytic leukemia; MDS-EB2, MDS with excess blasts; NA, not available; ND, not detected, D, detected.

Ann Lab Med 2025;45:53~61 https://doi.org/10.3343/alm.2024.0190

© Ann Lab Med